Medisca Aminocaproic Acid Recall: Industrial Product Labeled for Pharmacy Use
Medisca recalls Aminocaproic Acid (USP) jars and drums that were manufactured for industrial use but labeled for pharmacy compounding. This may pose risks if used in medical settings without proper safety checks.
Recall notice
CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.
Contact the company
What happened, in plain English
Medisca is recalling Aminocaproic Acid (USP) products that were made for industrial use but labeled for pharmacy compounding. This could lead to safety issues if used in medical settings without proper verification. Read more at govinfonow.com/recall/41252-medisca-aminocaproic-acid-recall-industrial-product-labeled-for-pharmacy-use.
Source Summary by GovInfoNow · govinfonow.com/recall/41252-medisca-aminocaproic-acid-recall-industrial-product-labeled-for-pharmacy-use · Updated October 7, 2026 · FDA enforcement record: FDA #D-1174-2017
Cite this page
“Medisca Aminocaproic Acid Recall: Industrial Product Labeled for Pharmacy Use.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41252-medisca-aminocaproic-acid-recall-industrial-product-labeled-for-pharmacy-use. Based on FDA recall #D-1174-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1174-2017%22&limit=1).
Why it’s dangerous
The product was manufactured for industrial use but labeled for pharmacy compounding. This mismatch could lead to improper use in medical settings, potentially causing safety issues if the product is not handled correctly.
Who’s affected
Pharmacy compounding professionals and medical facilities using this product may be affected. Those handling the product without verifying its intended use could face risks.
How to tell if you have this one
Check for NDC codes 38779-0989-05 (100g jar), 38779-0989-09 (1kg jar), or 38779-0989-07 (25kg drum). The product was manufactured for industrial use but labeled for pharmacy compounding.
- Brand
Medisca- Category
Drug
What to do — step by step
Check Product Label
Verify the product's intended use by checking the label for industrial or pharmacy compounding markings.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1174-2017 (September 14, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1174-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.